Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO
Business & Finance

A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO

Bloomberg Markets Thursday 30 July 2026, 12:02 UTC By David Morris 1 min read
Key Points

A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector. The San Francisco-based developer of drugs for cardiovascular diseases is offering 18.8 million shares for $15 to $17 each, according to a filing Thursday with the US Securities and Exchange Commission.

A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector. The San Francisco-based developer of drugs for cardiovascular diseases is offering 18.8 million shares for $15 to $17 each, according to a filing Thursday with the US Securities and Exchange Commission.
US (LOCATION) IPO A16z-Backed Biotech (ORG) San Francisco (LOCATION) the US Securities and Exchange Commission (ORG)
Originally published by Bloomberg Markets Read original →

Related Stories

MLB Power Rankings: Wild-card contenders surge and fall ahead of trade deadline

It's trade season in Major League Baseball, with Monday's trade deadline quickly approaching. And a number of teams throughout our rankings are sure to get in on the fun. Everyone around the sport is closely watching the Tigers (who dropped two spots on our list this week) and whether they'll decide to move baseball's best pitcher, Tarik Skubal.

ESPN just now

BOE's Lombardelli Says Holding Rates Was Right Thing to Do

Jul 30th, 2026 BOE's Lombardelli Says Holding Rates Was Right Thing to Do Bank of England Deputy Governor Clare Lombardelli says her vote to hold interest rates steady at 3.75% on Thursday was not a close judgment. "I was pretty clear that holding rates at the current level was the right thing to do," she says at a press conference in London following the central bank's decision to keep rates unchanged.

Bloomberg Markets 12m ago

Only the Middle East crisis is preventing a drop in UK interest rates

Bank’s wariness about inflationary pressures from the conflict lie behind decision to hold steady at 3.75%Business live – latest updatesThere is a threat of high inflation coming to the UK, but only from the conflict in the Middle East which could keep oil prices high for much longer than was expected when Donald Trump first began attacking Iran. It is the war that makes the difference between a benign outlook for inflation and one that puts it back on a rising trajectory, top UK central...

The Guardian Business 14m ago

Airbus fined £6.4m for breaching rules on export of sensitive technology

Manufacturer self-reported the offences to HMRC in the tax authority’s largest out-of-court settlementAirbus has been fined £6.4m in the UK after the European aerospace company admitted to multiple breaches of rules designed to stop sensitive goods such as military hardware falling into the wrong hands. The company, which sits at the heart of the European defence industry, said it had paid the settlement to the UK’s tax authority, HM Revenue and Customs, after self-reporting breaches that...

The Guardian World 17m ago